Transaction · 0001193125-26-385414

DANIELS BRIAN

DANIELS BRIAN, DIR, reported a transaction classified as grant at Artiva Biotherapeutics, Inc. involving 13750.000000 shares for an estimated $0.00. Reported holdings after the transaction were 13750.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
ARTVArtiva Biotherapeutics, Inc.
Filing timeSep 08
Trade dateSep 08, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$10.88
Pre-filing
1mo ago +3.6%1w ago +3.7%1d ago +2.8%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

ARTV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ARTV since 2026-09-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-385414
Director Stock Option (Right to Buy)
Transaction date
Sep 08, 2026
Filed Sep 08, 2026, 09:56 PM · 0d delay
Shares
13.7k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
13.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares subject to the option will vest in full on the earlier of September 8, 2027, or the date of the Issuer's 2027 annual stockholder meeting.

Original filing · 0001193125-26-385414
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ARTV